+ All Categories
Home > Documents > oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic...

oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic...

Date post: 21-Feb-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
30
Transcript
Page 1: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 2: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 3: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 4: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 5: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 6: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 7: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 8: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 9: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 10: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 11: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 12: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 13: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 14: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 15: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 16: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 17: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 18: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 19: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 20: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 21: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 22: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 23: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 24: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 25: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 26: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 27: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 28: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 29: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy
Page 30: oncologypro.esmo.org...Tao 1671." 2016 Design Phase I Retrospective Retrospective I ntra-hepatic perihilar Intra-hepatic perihilar Number patients 10 26 risk RT dose scheme ± Chemo-therapy

Recommended